Onderzoeker
Michaël Zalutsky
- Trefwoorden:Geneeskunde
- Disciplines:Humane wetenschappen en de kunsten, Ingenieurswetenschappen en technologie, Natuurwetenschappen
Affiliaties
- Ondersteunende Klinische wetenschappen (Departement)
Lid
Vanaf1 jan 2014 → 30 sep 2017 - Medische Beeldvorming (Onderzoeksgroep)
Lid
Vanaf1 okt 2013 → 30 sep 2017 - Medische Beeldvorming en Fysische Wetenschappen (Departement)
Lid
Vanaf1 okt 2013 → 31 dec 2013
Publicaties
1 - 10 van 32
- Synthesis and preliminary evaluation of 211At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancer(2021)
Auteurs: Ganesan Vaidyanathan, Ronnie C Mease, I L Minn, Jaeyeon Choi, Ying Chen, Hassan Shallal, Choong Mo Kang, Darryl McDougald, Vivek Kumar, Martin G Pomper, et al.
Pagina's: 67-80 - Heterogeneity and vascular permeability of breast cancer brain metastases(2020)
Auteurs: Maria V Babak, Michael R Zalutsky, Irina V Balyasnikova
Pagina's: 174-181 - Labeling a TCO-functionalized single domain antibody fragment with F-18 via inverse electron demand Diels Alder cycloaddition using a fluoronicotinyl moiety-bearing tetrazine derivative(2020)
Auteurs: Zhengyuan Zhou, Michael R Zalutsky, Ganesan Vaidyanathan
- Labeling Single Domain Antibody Fragments with Fluorine-18 Using 2,3,5,6-Tetrafluorophenyl 6-[ 18F]Fluoronicotinate Resulting in High Tumor-to-Kidney Ratios(2019)
Auteurs: Zhengyuan Zhou, Darryl Lynn McDougald, Nick Devoogdt, Michael R Zalutsky, Ganesan Vaidyanathan
Pagina's: 214-226 - An Efficient Method for Labeling Single Domain Antibody Fragments with 18F Using Tetrazine- Trans-Cyclooctene Ligation and a Renal Brush Border Enzyme-Cleavable Linker(2018)
Auteurs: Zhengyuan Zhou, Nick Devoogdt, Michael R Zalutsky, Ganesan Vaidyanathan
Pagina's: 4090-4103 - Synthesis and Evaluation of a 18F-Labeled Triazinediamine Analogue for Imaging Mutant IDH1 Expression in Gliomas by PET(2018)
Auteurs: Satish K Chitneni, Hai Yan, Michael R Zalutsky
Pagina's: 606-611 - Fluorine-18 labeling of an anti-HER2 VHH using a residualizing prosthetic group via a strain-promoted click reaction(2018)
Auteurs: Zhengyuan Zhou, Satish K Chitneni, Nick Devoogdt, Michael R Zalutsky, Ganesan Vaidyanathan
Pagina's: 1939-1949 - Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation(2017)
Auteurs: Zhengyuan Zhou, Ganesan Vaidyanathan, Darryl McDougald, Choong Mo Kang, Irina Balyasnikova, Nick Devoogdt, Angeline N Ta, Brian R McNaughton, Michael R Zalutsky
Pagina's: 867-877 - I-131-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment(2017)
Auteurs: Matthias D'Huyvetter, Jens De Vos, Catarina Xavier, Marek Pruszynski, Yann G-J Sterckx, Sam Massa, G Raes, Vicky Caveliers, Michael R Zalutsky, Tony Lahoutte, et al.
Pagina's: 6616-6628 - Preparation, cytotoxicity, and in vivo antitumor efficacy of (111)In-labeled modular nanotransporters(2017)
Auteurs: Tatiana A Slastnikova, Andrey A Rosenkranz, Natalia B Morozova, Maria S Vorontsova, Vasiliy M Petriev, Tatiana N Lupanova, Alexey V Ulasov, Michael R Zalutsky, Raisa I Yakubovskaya, Alexander S Sobolev
Pagina's: 395-410